Vaginal Pessary Market Size, Share & Industry Analysis, By Product Type (Vaginal Ring, Gehrung, Gellhorn, Cube, Others) By Disease Indication (Pelvic Organ Prolapse, Urinary Incontinence), By End-user (Hospital Pharmacy, Retail Pharmacy, Online Stores, Others), and Regional Forecast, 2024-2032

A vaginal pessary is a medical device, inserted in the vagina to support pelvic organs such as uterus, vagina, bladder, or rectum to deliver medications. There are various types of vaginal pessaries available in the market, such as vaginal rings, gellhorn, cubes, gehrung, and others. Pessaries are used in the non- surgical approach in the treatment of the pelvic organ prolapse and urinary incontinence. In pelvic organ prolapse, the tissues and muscles supporting the pelvic organs become weak or loose. This allows the pelvic organs (the bladder, uterus, small intestine, part of the vagina, and rectum) to protrude into or at times out of the vagina. There is a gradual shift towards the use of vaginal rings over vaginal mesh among women for the treatment of pelvic organ prolapse, which is positively impacting the vaginal pessary industry.

Global vaginal pessary market growth is being driven by the rising prevalence of pelvic organ prolapse, increasing geriatric population, easy availability of the products, and rapid adoption of non-invasive treatment devices. Furthermore, rising concern for women’s health has encouraged active government interventions, and guidelines on the use of vaginal pessary are anticipated to accelerate the growth of the global vaginal pessary market.

However, complications such as the formation of an opening between the vagina and the rectum, bleeding, open sores, and irritation caused due to use of pessaries are the major factors that can hinder the growth of the global vaginal pessary market.

Key Players Covered:

The key companies covered in the global Vaginal Pessary market report include CooperSurgical, Inc., Personal Medical Corp., Artisan Medical, Bioteque America, Inc., MEDGYN PRODUCTS, INC., Panpac Medical Corp., Integra LifeSciences Corporation, Dr. Arabin GmbH & Co. KG and Other Prominent Players.

As per the current Vaginal Pessary market trends, vaginal rings among the product type are anticipated to hold a higher market share in the global vaginal pessary market owing to increasing usage of vaginal rings and easy availability of the products. Moreover, the risk of vaginal bleeding associated with vaginal mesh has resulted in a rising preference for vaginal rings among women, which is expected to increase the demand for vaginal rings during the forecast duration.

Key Insights:

• Prevalence of Pelvic Organ Prolapse for key countries


• Prevalence of Urinary Incontinence for key countries


• Comparison of the Types of Pessaries - Applications, Benefits, and Limitations


• The regulatory scenario for key countries


• New product launch


• Key mergers and acquisitions

Regional Analysis:

The global vaginal pessary market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the vaginal pessary market over the forecast period owing to the increasing prevalence of pelvic organ prolapse, the strategic presence of manufacturers, and the increase in demand for vaginal pessary rings. According to The Office on Women's Health, 3% of the U.S. women population was affected by pelvic organ prolapse in 2016, which is likely to favor the vaginal pessary market in North America.

In Europe, the vaginal pessary market is projected to grow owing to the favorable government policies for women’s health and rapid adoption of sedentary lifestyles leading to hormonal imbalance. The vaginal pessary market in Asia Pacific is expected to register considerable growth owing to the increased government efforts and awareness regarding vaginal pessary devices. In Latin America, and Middle East and Africa, the vaginal pessary market is projected to expand, which is attributable to the increased efforts of key manufacturers to penetrate into these regions and improving healthcare infrastructure.

Segmentation

Vaginal Pessary Industry Developments

• In October 2018, Panpac Medical Corporation received 510 (k) approval for Panpac Flexi Shelf Pessary from the FDA.


• In July 2016, Panpac Medical Corporation received 510 (k) approval for Panpac Disposable Pessary Fitting Set from FDA for the treatment of uterine prolapse and stress urinary incontinence.


• In July 2015, Royal College of Obstetricians and Gynaecologists and British Society of Urogynaecology issued guidelines for Post-Hysterectomy Vaginal Vault Prolapse recommending the use of vaginal pessaries.